Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of ertapenem in thrice-weekly dosing after hemodialysis in end-stage renal disease
2010-020492-23Phase 4Active
- Sponsor
- Franciscus Gasthuis & Vlietland
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ertapenem in bacterial disease, sponsored by Franciscus Gasthuis & Vlietland. Primary endpoint: Adequate trough levels of ertapenem. Started Jun 2010; status: active.
02
Drugs
ertapenem
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2010-020492-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020492-23.